FDA Import Refusal SCS-7901634-3/11/1 — Novo Nordisk Inc.
The FDA refused shipment SCS-7901634-3/11/1 from Novo Nordisk Inc. (United States) on Dec 2, 2021. The refused product falls under Drugs and Biologics — GLUCAGON (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 2, 2021
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP10 GLUCAGON (ANTI-DIABETIC)
- Charges
- 75